First-in-human clinical study of an embryonic stem cell product for urea cycle disorders

Abstract Background This study assesses the safety and efficacy of hepatocyte-like cell (HLC) infusion therapy derived from human embryonic stem cells as bridging therapy for neonatal-onset urea cycle disorders (UCD). The research includes both preclinical and clinical evaluations to determine the f...

Full description

Bibliographic Details
Published in:Stem Cell Research & Therapy
Main Authors: Akihiro Umezawa, Akinari Fukuda, Reiko Horikawa, Hajime Uchida, Shin Enosawa, Yoshie Oishi, Naoko Nakamura, Kengo Sasaki, Yusuke Yanagi, Seiichi Shimizu, Toshimasa Nakao, Tasuku Kodama, Seisuke Sakamoto, Itaru Hayakawa, Saeko Akiyama, Noriaki Saku, Shoko Miyata, Kenta Ite, Palaksha Kanive Javaregowda, Masashi Toyoda, Hidenori Nonaka, Kazuaki Nakamura, Yoshikazu Ito, Yasuyuki Fukuhara, Osamu Miyazaki, Shunsuke Nosaka, Kazuhiko Nakabayashi, Chizuko Haga, Takako Yoshioka, Akira Masuda, Takashi Ohkura, Mayu Yamazaki-Inoue, Masakazu Machida, Rie Abutani-Sakamoto, Shoko Miyajima, Hidenori Akutsu, Yoichi Matsubara, Takashi Igarashi, Mureo Kasahara
Format: Article
Language:English
Published: BMC 2025-03-01
Subjects:
Hepatocyte
Embryonic stem cells (ESCs)
Urea cycle disorders (UCD)
Liver transplantation
Neonatal-onset
Ammonia removal
Online Access:https://doi.org/10.1186/s13287-025-04162-3

Internet

https://doi.org/10.1186/s13287-025-04162-3

Similar Items